The advent of targeted therapies transformed the treatment of metastatic RCC. Sun et al. provide a comprehensive summary of the published evidence for the efficacy of immunotherapy, cytoreductive nephrectomy and targeted therapies in treating this disease. They highlight sequential approaches and offer clinical recommendations for the contemporary patient.
- Maxine Sun
- Giovanni Lughezzani
- Pierre I. Karakiewicz
